HomeClinical TopicsFDA approved Adempas for pulmonary hypertension

FDA approved Adempas for pulmonary hypertension

Author(s):

On Sept. 30, the U.S. Food and Drug Administration (FDA) approved Adempas (riociguat) to treat adults with two forms of pulmonary hypertension. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content